^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    AssureMDx

    Company:
    Vesica Health
    Type:
    Laboratory Developed Test
    Details
    Evidence

    News

    20d
    Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx (Vesica Health Press Release)
    "VESICA HEALTH®...today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to its AssureMDx test."
    Clinical
    |
    AssureMDx
    3ms
    Urinary biomarkers in multicentric studies: Shaping the future of bladder cancer diagnosis and follow-up. (PubMed, BJUI Compass)
    Urine-based biomarkers have the potential to improve early BC detection and surveillance while reducing reliance on invasive procedures and costs related to the disease. Future efforts should prioritize cost-effective, large-scale multicentric studies to facilitate the adoption of these biomarkers into routine practice.
    Review • Journal
    |
    AssureMDx • Cxbladder
    6ms
    Vesica Health Receives AUA Guideline Inclusion ()
    "VESICA HEALTH®...today announced that its flagship test, AssureMDx, has been formally recognized in the newly updated American Urological Association (AUA) Guidelines for the evaluation of patients with microscopic hematuria. Hematuria—blood in the urine—is the most common presenting symptom of bladder cancer."
    Clinical guideline
    |
    AssureMDx
    almost2years
    Vesica Health announces launch of AssureMDx Test to improve bladder cancer detection (PRNewswire)
    "VESICA HEALTH, INC...announced the launch of its laboratory-developed AssureMDx™ test...AssureMDx represents a significant leap forward in bladder cancer diagnostics, offering unparalleled accuracy and reliability backed by rigorous scientific validation."
    Launch
    |
    AssureMDx